Payer concentration is the degree to which a medical practice's revenue depends on one or a small number of insurance payers, creating financial and negotiating risk when a dominant payer reduces reimbursement rates, narrows its network, or terminates a contract.
Payer concentration measures the proportion of a practice's revenue attributable to its top payers: a practice where a single commercial insurer accounts for 45% of revenue has high concentration that creates material leverage risk in contract negotiations — the payer knows that terminating or reducing reimbursement would be financially devastating to the practice. High payer concentration is particularly risky in markets where a single health system owns the dominant commercial plan, or where state Medicaid managed care organizations are consolidated into one or two plans that most of the market must contract with. Payer concentration risk is distinct from payer mix risk: payer mix describes the composition of revenue across categories (commercial, Medicare, Medicaid, self-pay), while payer concentration describes dependence on a specific insurer within those categories. Healthcare investors evaluate payer concentration during due diligence by reviewing the commercial payer contract portfolio for term dates, reimbursement rates relative to Medicare, and the practice's alternative options if a specific payer terminates. A practice with three commercial payers each representing 15–20% of revenue has significantly better negotiating leverage and risk diversification than one where a single payer represents 50%+ of commercial volume.
Every engagement starts with a 30-minute discovery call — we'll look at your EHR and show you exactly where the gaps are.
Schedule a Discovery Call